Migration of arterial wall cells. Expression of plasminogen activators and inhibitors in injured rat arteries

Circulation Research
M A ReidyV Lindner

Abstract

The expression of plasminogen activators and inhibitors was examined in denuded arteries. Within 5 days, smooth muscle cells (SMCs) on the luminal surface expressed the mRNA for tissue-type plasminogen activator (TPA), urokinase type plasminogen (UPA), the receptor for UPA (UPAR), and plasminogen activator inhibitor type-1 (PAI-1). Similar results were seen after 8 days. Six weeks later, only TPA mRNA was still expressed by SMCs on the luminal surface. En face casein zymograms revealed a net fibrinolytic activity in areas covered with luminal SMCs. Reverse zymography showed no antifibrinolytic activity in these zones. Quiescent endothelial cells did not express TPA, UPA, UPAR, or PAI-1 mRNA. Regenerating endothelium at the wound edge strongly expressed TPA. UPA, and UPAR, as well as PAI-1. UPA and UPAR expression was highly restricted to cells at the wound edge and was not present elsewhere. En face zymography showed no plasmin activity in endothelialized areas, and reverse zymography showed a net fibrinolytic activity in endothelialized zones. These results suggest that plasminogen activator and inhibitor expression correlates with the migration of both SMCs and endothelial cells into an arterial wound.

References

Nov 1, 1992·Experimental Cell Research·P RagnoJ D Vassalli
Aug 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·J SchneidermanD J Loskutoff
Dec 2, 1990·Cell Differentiation and Development : the Official Journal of the International Society of Developmental Biologists·M S Pepper, R Montesano
Sep 1, 1991·The Journal of Clinical Investigation·M W MajeskyM A Reidy
May 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·V Lindner, M A Reidy
Sep 1, 1988·The Journal of Clinical Investigation·J N WilcoxD Gordon
Jan 1, 1985·Advances in Cancer Research·K DanøL Skriver
Aug 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·M P StoppelliR K Assoian
Oct 1, 1986·Seminars in Thrombosis and Hemostasis·R H Goldfarb, L A Liotta
Jan 1, 1988·Annual Review of Cell Biology·O Saksela, D B Rifkin
Jan 1, 1984·Seminars in Thrombosis and Hemostasis·F Bachmann, I E Kruithof
May 1, 1994·The Journal of Cell Biology·T F LaneE H Sage
Aug 1, 1994·The Journal of Experimental Medicine·G K HanssonE Jennische
Mar 1, 1994·The Journal of Clinical Investigation·Y G WolfE Ruoslahti
Jan 1, 1994·Trends in Pharmacological Sciences·F Fazioli, F Blasi
Aug 1, 1993·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·C L JacksonM A Reidy
Aug 1, 1993·The Journal of Cell Biology·M S PepperJ D Vassalli

❮ Previous
Next ❯

Citations

Sep 8, 2000·Bulletin of Experimental Biology and Medicine·O S PlekhanovaE V Parfenova
Nov 5, 1997·Progress in Cardiovascular Diseases·P Libby, H Tanaka
May 14, 2003·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Raymond L BenzaJames F George
Mar 14, 2003·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Raymond L Benza
Jun 2, 1998·Kidney International·P Carmeliet, D Collen
Mar 11, 2009·Circulation·Ciprian B AneaR Daniel Rudic
Jan 15, 1997·The Journal of Clinical Investigation·P CarmelietD Collen
Mar 7, 2001·In Vitro Cellular & Developmental Biology. Animal·D K ZablockiB R Alevriadou
Mar 21, 1998·Transplant Immunology·S M Schwartz
Feb 16, 1999·The Journal of Investigative Dermatology·P J Jensen, R M Lavker
May 1, 2015·Thrombosis and Haemostasis·M UnseldG W Prager
Jan 18, 2005·Experimental Eye Research·Zhiyu WangMichelle Kurpakus-Wheater
Jun 21, 2005·The Journal of Surgical Research·Irfan I GalariaMark G Davies
Feb 26, 2016·Clinical Pharmacology and Therapeutics·M D BallantyneA H Baker
Jun 7, 2000·The Journal of Surgical Research·S J BusuttilE F Plow
Feb 24, 2000·The Journal of Pathology·A C Newby, A B Zaltsman
Sep 16, 2004·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Friedhelm Beyersdorf
Apr 17, 2009·Canadian Journal of Physiology and Pharmacology·Vsevolod A TkachukYelena V Parfyonova
Jun 3, 2004·Journal of Cellular Physiology·Kirwin M Providence, Paul J Higgins
Mar 21, 2003·Journal of Cellular Biochemistry·Xavier HouardMaurice Pagano
Dec 7, 2013·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Nelisa T Laçin, Guldem G Utkan
Mar 21, 2002·Journal of Cardiovascular Pharmacology·Atai WatanabeMasahiko Kurabayashi
Aug 23, 2002·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·H K F Lau, J Ho
Nov 26, 2010·Immunology and Cell Biology·Giuseppina F DusioCristiano Rumio
Oct 22, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Wei-Jun CaiJutta Schaper
May 9, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·A A BickerstaffC G Orosz
Apr 13, 2000·International Journal of Experimental Pathology·G A Ferns, T Y Avades
Apr 6, 2001·American Journal of Physiology. Lung Cellular and Molecular Physiology·A CouttsN Khalil

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.